Zus Health, a Boston-based startup that runs a shared data platform for patient records, has raised a 33 million dollar Series B round led by Drive Capital. According to reporting by Fierce Healthcare and funding trackers, the round lifts the company's total funding to roughly 107 million dollars.
Zus describes its product as a shared health data platform: instead of every application in a hospital building its own pipeline to pull and reconcile patient records, Zus maintains one interoperable view that care teams and software vendors can build on. The company is now framing that infrastructure as the essential substrate for the next wave of clinical AI, where assistants and agents need clean, consolidated patient context before they can safely draft notes, summarize histories or suggest next steps.
The timing is not accidental. The past two years have seen a rush of AI products into hospitals, from ambient scribes to coding assistants and prior-authorization tools, and regulators have cleared more than 1,600 AI-enabled medical devices in the United States as of September 2026. But nearly every deployment runs into the same wall: patient data is scattered across electronic record systems, payer portals and unstructured documents. Startups that solve that plumbing problem quietly become dependencies for everyone else.
Zus has been building in that space since before the current boom. The company's pitch to investors is that AI raises the value of its core product rather than replacing it, because a model that reasons over a fragmented record produces fragmented answers. A 33 million dollar check from Drive Capital, a firm that has backed several healthcare data companies, suggests investors buy that framing.
The funding also lands in a market where capital is concentrating quickly. In the same week that Zus closed its round, peer-to-peer medical education platform Vumedi raised a 104 million dollar Series B led by Oak HC/FT, chart-review startup Charta Health pulled in 55 million dollars, and medical AI training-environment startup Alterra Labs raised 12.5 million dollars. Health systems, meanwhile, are moving from pilots to procurement, which is when data-layer vendors tend to see their contracts expand.
The competitive question will be whether hospital-grade interoperability stays a product category of its own or gets absorbed by the electronic record vendors themselves, who own the source systems and have their own AI ambitions. Zus's answer, as it presented it in announcing the round, is neutrality: one shared record view that works across systems and vendors, sold to the growing ecosystem of clinical AI tools rather than to any single one of them.
For now, the company has fresh capital, a clearly stated wedge into the AI-in-healthcare buildout, and a customer base that includes both provider organizations and software vendors. The 33 million dollars buys it a longer runway to prove that the data layer, not the model, is where clinical AI gets built.
Comments (0)
Log in to join the discussion
Log InNo comments yet